Condensed Consolidated Statements of Operations | |
Revenue | 139.05M |
Cost of revenue | 54.83M |
Gross profit | 84.22M |
Operating costs and expenses: | |
Research and development | 31.32M |
Selling, general and administrative | 22.78M |
Amortization of purchased intangibles | 2.67M |
Restructuring | 14K |
Acquisition-related costs | |
Operating income | 22.8M |
Interest income | |
Interest expense and fees | -340K |
(Loss) gain on deferred compensation investments, net | |
Other-than-temporary impairment losses | |
Income before income taxes | |
Income tax expense | 7.03M |
Net income (loss) | |
Earnings (loss) per share: | |
Basic | 0.12 |
Diluted | 0.11 |
Cash dividends declared per common share | 0.12 |
Weighted average common shares outstanding (in millions): | |
Basic | 135.91M |
Diluted | 138.76M |